Senores Pharmaceuticals (NSE:SENORES) Total Stockholders Equity: ₹ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SENORES Senores Pharmaceuticals Ltd NSE:SENORES
21 GF Score
Price ₹1,395.10
! 7 Warning Signs
View Full Analysis

What is Senores Pharmaceuticals Total Stockholders Equity?

Senores Pharmaceuticals NSE:SENORES 21 Total Stockholders Equity is ₹ Mil as of Jun. 2026. GuruFocus rates NSE:SENORES with a GF Score™ of 21/100. The stock has 7 warning signs investors should review.

Senores Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ₹ Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Senores Pharmaceuticals's Book Value per Share for the quarter that ended in Jun. 2026 was ₹N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Senores Pharmaceuticals's Debt-to-Equity for the quarter that ended in Jun. 2026 was .

Senores Pharmaceuticals  (NSE:SENORES) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Senores Pharmaceuticals's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-)/46.05359
=N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Senores Pharmaceuticals's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=( + ) /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senores Pharmaceuticals Total Stockholders Equity Related Terms

Senores Pharmaceuticals Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Senores Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senores Pharmaceuticals Total Stockholders Equity Chart

Senores Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Stockholders Equity
365.90 454.99 2,042.70 7,861.90 9,336.00

Senores Pharmaceuticals Quarterly Data
Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only - 8,140.10 - 9,336.00 -
NSE:SENORES
21GF Score
Senores Pharmaceuticals Ltd NSE:SENORES
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of ₹ Mil mean?
Senores Pharmaceuticals (NSE:SENORES) has a Total Stockholders Equity of ₹ Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Senores Pharmaceuticals and its competitors.
Is Senores Pharmaceuticals' Total Stockholders Equity too high?
Senores Pharmaceuticals' current Total Stockholders Equity is ₹ Mil. Overall, Senores Pharmaceuticals has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Senores Pharmaceuticals' Total Stockholders Equity compare to LLY and JNJ?
Senores Pharmaceuticals' Total Stockholders Equity of ₹ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Senores Pharmaceuticals and its competitors. Senores Pharmaceuticals's current Total Stockholders Equity is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senores Pharmaceuticals stock overvalued right now?
Senores Pharmaceuticals (NSE:SENORES) has a current Total Stockholders Equity of ₹ Mil. The current Total Stockholders Equity is ₹ Mil. Senores Pharmaceuticals' overall GF Score™ is 21/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Senores Pharmaceuticals (NSE:SENORES), the current Total Stockholders Equity is ₹ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Senores Pharmaceuticals Business Description

Other Exchanges 544319:India
Address Ambali Bopal Road, 1101 to 1103, 11th floor, South Tower, ONE 42, Opposite Jayantilal Park, Ahmedabad, GJ, IND, 380054
Senores Pharmaceuticals Ltd is an India-based pharmaceutical company that develops, manufactures and sells pharmaceutical products for regulated markets such as the United States and other developed economies, as well as emerging markets. It focuses on specialty, underpenetrated and complex products across multiple therapeutic areas and dosage forms, including oral solids, injectables and other formulations. The company identifies commercially attractive molecules through data analytics, research and market assessment, then develops and commercializes them, often as a preferred manufacturing and supply partner to other pharmaceutical companies. Its customers include pharmaceutical distributors, wholesalers, hospitals and healthcare providers in India and abroad. Revenue is generated primarily from the sale of finished dosage formulations and related products, with a significant share coming from international markets. The company operates manufacturing and research facilities in India and maintains a presence in overseas markets through subsidiaries and partnerships.
21GF Score

Get the complete analysis for NSE:SENORES

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,395.10
Price